Literature DB >> 9596066

The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients.

J Russo1, C A Trujillo, D Wingerson, K Decker, R Ries, H Wetzler, P Roy-Byrne.   

Abstract

OBJECTIVES: The authors test the reliability and validity of the Medical Outcomes Study Short Form 36-Item Health Survey (SF-36) as a written, self-administered survey in outpatients with chronic schizophrenia.
METHODS: Thirty-six schizophrenic outpatients completed a written and oral form of the SF-36. A psychiatrist rated the patients using the Brief Psychiatric Rating Scale to determine severity of psychopathology. Cognitive functioning and academic achievement were also assessed. Internal consistency, test-retest reliability, concurrent and discriminative validity of the oral and written versions were determined.
RESULTS: The SF-36 in both forms was shown to have good internal consistency, stability, and concurrent validity. The mental health SF-36 subscales had poor discriminant validity, compared with the physical functioning scale that demonstrated good discriminant validity.
CONCLUSIONS: The validity of using the written form of the SF-36 on a sample of patients with chronic mental illness was demonstrated. The SF-36 appears to be an appropriate outcome measure for changes in physical and role functioning in consumers of outpatient mental health programs.

Entities:  

Mesh:

Year:  1998        PMID: 9596066     DOI: 10.1097/00005650-199805000-00015

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  30 in total

1.  Further validation of the Psycho-Social Well-Being Scale (PSWS) with community clients.

Authors:  Thomas O'Hare; Margaret V Sherrer; Hilary Smith Connery; Jay Thornton; Annamaria LaButti; Kelly Emrick
Journal:  Community Ment Health J       Date:  2003-04

2.  Psychosocial functioning and quality of life in body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard; Christina Fay; Maria E Pagano
Journal:  Compr Psychiatry       Date:  2005 Jul-Aug       Impact factor: 3.735

3.  A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.

Authors:  Nan Luo; Boon-Kheng Seng; Julian Thumboo; David Feeny; Shu-Chuen Li
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

4.  Measurement limit of quality-of-life questionnaires in psychiatric settings.

Authors:  Takeshi Nishiyama; Norio Ozaki
Journal:  Qual Life Res       Date:  2009-11-21       Impact factor: 4.147

5.  Comparison of schizophrenia outpatients in residential care facilities with those living with someone: Study of mental and physical health, cognitive functioning, and biomarkers of aging.

Authors:  Ellen E Lee; Averria Sirkin Martin; Christopher N Kaufmann; Jinyuan Liu; Julie Kangas; Rebecca E Daly; Xin M Tu; Colin A Depp; Dilip V Jeste
Journal:  Psychiatry Res       Date:  2019-02-27       Impact factor: 3.222

6.  Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day-A Double-blind, Placebo- and Active-Controlled, Study in the Treatment of Patients with Schizophrenia.

Authors:  Danielle Coppola; Rama Melkote; Caroline Lannie; Jaskaran Singh; Isaac Nuamah; Srihari Gopal; David Hough; Joseph Palumbo
Journal:  Psychopharmacol Bull       Date:  2011-05-15

7.  The psychosocial work environment and mental health of teachers: a comparative study between the United Kingdom and Hong Kong.

Authors:  Jessica Janice Tang; Stavroula Leka; Sara MacLennan
Journal:  Int Arch Occup Environ Health       Date:  2012-07-27       Impact factor: 3.015

8.  The health-related quality of life in eating disorders.

Authors:  A Padierna; J M Quintana; I Arostegui; N Gonzalez; M J Horcajo
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

9.  Reducing recidivism and symptoms in emerging adults with serious mental health conditions and justice system involvement.

Authors:  Maryann Davis; Ashli J Sheidow; Michael R McCart
Journal:  J Behav Health Serv Res       Date:  2015-04       Impact factor: 1.505

Review 10.  Assessing the value of antipsychotics for treating schizophrenia: the importance of evaluating and interpreting the clinical significance of individual service costs.

Authors:  Sandra L Tunis; Haya Ascher-Svanum; Michael Stensland; Bruce J Kinon
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.